Lotte Chemical Titan Tbk PT (FPNI) fair value: what the stock is really worth
As of Oct 23, 2026: fair value (intrinsic value) of Lotte Chemical Titan Tbk PT stock IDR 230, price IDR 426, upside -46.0%, quality 70 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 21, 2026.
How to read this chart
60‑month range 141.00 IDR – 1,725 IDR · fair‑value band 210.22 IDR – 287.68 IDR · the 426.00 IDR price screens above the 230.14 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Oct 21, 2026.
Follow Lotte Chemical Titan Tbk PT in your weekly email
Every Wednesday you see whether Lotte Chemical Titan Tbk PT is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
PT Lotte Chemical Titan Tbk, together with its subsidiaries, engages in the production and distribution of polyethylene products in Indonesia.
Show moreShow less
The company produces linear low density polyethylene resins used in film, wire and cable, rotational molding, and others extrusion applications; high density polyethylene resins used in injection and blow molding, extrusion, and film applications; low density polyethylene with applications, including food packaging films, heavy duty bags, injection molded articles, crates, industrial pails, chicken cages, dustbins, and container lids; and polypropylene homopolymers, and polypropylene random and impact copolymers, as well as BOPP films.
It also involved in the trading and importation of polyethylene and polypropylene, as well as wholesale trading of rubber and plastics in basic form. The company was formerly known as P.T. Titan Kimia Nusantara Tbk and changed its name to PT Lotte Chemical Titan Tbk in April 2013.
PT Lotte Chemical Titan Tbk was incorporated in 1987 and is headquartered in Jakarta, Indonesia. PT Lotte Chemical Titan Tbk operates as a subsidiary of Lotte Chemical Titan International Sendirian Berhad.
Stock analysis
Lotte Chemical Titan Tbk PT (FPNI) currently trades at 426.00 IDR, while our model-based Fair Value estimate is 230.14 IDR, 46.0% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of 805.23 IDR per share, and 9 of the 16 models we run sit above the 426.00 IDR price.
Bear case: the Asset-Based group reads lowest at 51.16 IDR, and 7 of the 16 models stay below the price. Data coverage for this calculation is low.
Scenario range: 210.22 IDR (bear) to 287.68 IDR (bull), the price of 426.00 IDR sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 70/100 (solid quality), in the Basic Materials sector.
Weak Growth: Revenue growth is weak: less than 2 % a year.
Lotte Chemical Titan Tbk PT reported revenue of $317M in FY2025 versus $412M in FY2021, a compound −6.4%/yr. Reported net income was $4.2M in FY2025, compounding −18.6%/yr from FY2021.
Key figures
Market cap 2.4T IDR (≈ $132M) Micro · P/E ratio 7.9 · P/S ratio 0.10 · EPS (TTM) 54.01 IDR · Net margin 1.3% · Return on equity 16.1% · Return on assets (EBIT) −2.1% · Operating margin 8.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 43 out of 100 (low confidence).
What moves the price
The share trades about 75% below its 52-week high and 125% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −55% fair-value upside, at −46%, FPNI screens cheaper than that median.
Fair Value models
Bear210.22 IDRFair Value 230.14 IDRBull287.68 IDR
Price 426.00 IDR · Upside -46.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (43.95 IDR per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
−13.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−12.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.5%
Start year 2020 (pandemic). Over 10 years: −3.6% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−24.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−15.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year−15.2%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−15.2% vs 5.0%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−3% → −3%
Pace: the 5-year rate starts in 2020 (pandemic)
⚠ Revenue per share shrinking 4.6%/yr over ~10Y (margin trend unclear) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−14.4%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −16.4% a year for the price.
Compare Lotte Chemical Titan Tbk PT with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 713 stocks
Beats the industry median on 8/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score70 · Top 25%
Fair Value upside−46.0% · Below median
Profitability
Return on equity (12 months)16.1% · Top 25%
Return on assets2.4% · Below median
Net margin (12 months)4.8% · Below median
Operating margin (12 months)8.6% · Below median
Growth and dividend
Revenue growth (quarter YoY)41.9% · Top 25%
Balance sheet
Debt / equity0.22× · Above median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (12 months)7.9× · Cheapest 25%
P/B1.28× · Cheaper than median
P/S (12 months)0.38× · Cheapest 25%
Price / free cash flow4.3× · Cheapest 25%
EV/EBITDA7.6× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 61
PAST (return on equity)64· sector 26
HEALTH (low debt)89· sector 95
DIVIDEND (yield)0· sector 29
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Lotte Chemical Titan Tbk PT Fair Value". https://www.fairvalue-calculator.com/stock/FPNI
Frequently asked questions
Is Lotte Chemical Titan Tbk PT (FPNI) overvalued or undervalued?
As of Oct 21, 2026, our model estimates a fair value of 230.14 IDR versus a price of 426.00 IDR, about −46% upside (overvalued).
What is the fair value of FPNI?
Our model-based fair value for Lotte Chemical Titan Tbk PT is 230.14 IDR (as of Oct 21, 2026), built from audited fundamentals. The current price: 426.00 IDR.
What is the quality score of FPNI?
Lotte Chemical Titan Tbk PT has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Lotte Chemical Titan Tbk PT (FPNI)?
Our model-based price target is the fair value of 230.14 IDR (as of Oct 21, 2026) from 16 valuation models. Cautious scenario 210.22 IDR, optimistic scenario 287.68 IDR. It is a calculation from audited fundamentals, not an analyst target.
What is the Lotte Chemical Titan Tbk PT stock forecast for 2026?
Our models put fair value at 230.14 IDR, about −46% upside versus a price of 426.00 IDR (overvalued). Cautious scenario 210.22 IDR, optimistic scenario 287.68 IDR. The calculation is refreshed regularly with new filings.
What is the revenue of Lotte Chemical Titan Tbk PT (FPNI)?
Lotte Chemical Titan Tbk PT reported trailing-twelve-month revenue of about $344M (latest available figure, as of Oct 21, 2026).
What growth is priced into Lotte Chemical Titan Tbk PT (FPNI)?
For today's price to be fair in a discounted-cash-flow model, Lotte Chemical Titan Tbk PT would have to grow free cash flow by -14.4 % per year for five years (discount rate 15.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +0.5 % per year. As of Oct 21, 2026.
What discount rate (WACC) does the fair value of FPNI use?
Our models discount Lotte Chemical Titan Tbk PT at 15.0 %: a base by market capitalisation (micro), country premium for Indonesia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Lotte Chemical Titan Tbk PT that is -14.4 % per year a year over ten years, using the same discount rate (15.0 %) and the same formula as our fair value.
How much growth has Lotte Chemical Titan Tbk PT (FPNI) delivered so far?
Over the past 5 years revenue at Lotte Chemical Titan Tbk PT grew +0.5 % a year. The price currently implies -14.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Lotte Chemical Titan Tbk PT (FPNI) growing?
The median revenue growth in the sector is +9.5 % a year. That is the yardstick for the growth priced into Lotte Chemical Titan Tbk PT (-14.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Lotte Chemical Titan Tbk PT (FPNI)?
The free-cash-flow yield on the price is 23.10 %: that much free cash flow Lotte Chemical Titan Tbk PT produces per unit of market value. When it exceeds the discount rate of our models (15.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Lotte Chemical Titan Tbk PT (FPNI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Lotte Chemical Titan Tbk PT it is 230.14 IDR per share (as of Oct 21, 2026), against a price of 426.00 IDR. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is Lotte Chemical Titan Tbk PT stock overvalued or undervalued in 2026?
As of Oct 21, 2026, FPNI trades above its calculated fair value: price 426.00 IDR, fair value 230.14 IDR, a gap of about −46% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of FPNI?
No. The price is what the market pays today (426.00 IDR); the fair value is what the company's own numbers justify (230.14 IDR). For Lotte Chemical Titan Tbk PT the two are 195.86 IDR per share apart. That gap is exactly why we show both numbers side by side.
How much is Lotte Chemical Titan Tbk PT worth?
The market values Lotte Chemical Titan Tbk PT at about 2.4T IDR (market capitalisation, as of Oct 21, 2026). Per share that is 426.00 IDR; our models calculate a fair value of 230.14 IDR per share.
What do the bullish and bearish scenarios say about FPNI?
Our models span a range for Lotte Chemical Titan Tbk PT: cautious scenario 210.22 IDR, base 230.14 IDR, optimistic 287.68 IDR per share (as of Oct 21, 2026, price 426.00 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of FPNI?
Lotte Chemical Titan Tbk PT trades at a price-to-earnings ratio of 7.9 (as of Oct 21, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 230.14 IDR is built from several models across several years. Other multiples: P/B 1.3, P/S 0.4, EV/EBITDA 7.6.
How solid is the balance sheet of Lotte Chemical Titan Tbk PT (FPNI)?
Balance-sheet figures for Lotte Chemical Titan Tbk PT (as of Oct 21, 2026): return on equity 16.1%, debt of 0.22 per unit of equity. They feed the Quality Score of 70/100, which measures business quality independently of the share price.
How far is FPNI from its 52-week high?
Lotte Chemical Titan Tbk PT trades at 426.00 IDR, about 75% below its 52-week high of 1,725 IDR and 125% above the low of 189.00 IDR (as of Oct 23, 2026). Distance from the high says nothing about value: that is what the fair value of 230.14 IDR is for.
Which stocks are comparable to Lotte Chemical Titan Tbk PT?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Lotte Chemical Titan Tbk PT stock attractive at the current price?
The data as of Oct 21, 2026: price 426.00 IDR, calculated fair value 230.14 IDR (−46%), Quality Score 70/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of FPNI calculated?
We run Lotte Chemical Titan Tbk PT through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 230.14 IDR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.3 % above its aggregate fair value. Lotte Chemical Titan Tbk PT itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Lotte Chemical Titan Tbk PT (FPNI)?
The closing price on Oct 23, 2026 was 426.00 IDR. Our model-based fair value is 230.14 IDR, about −46% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Lotte Chemical Titan Tbk PT right now?
A high-quality business (quality 70/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case (287.68 IDR). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Lotte Chemical Titan Tbk PT
How large is the market capitalisation of Lotte Chemical Titan Tbk PT (FPNI)?
The market capitalisation of Lotte Chemical Titan Tbk PT is 2.4T IDR (≈ $132M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Lotte Chemical Titan Tbk PT (FPNI)?
The price-to-sales ratio of Lotte Chemical Titan Tbk PT is 0.10 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Lotte Chemical Titan Tbk PT (FPNI)?
Earnings per share at Lotte Chemical Titan Tbk PT are 54.01 IDR (price ÷ EPS = P/E 7.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Lotte Chemical Titan Tbk PT (FPNI)?
The net margin of Lotte Chemical Titan Tbk PT is 1.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Lotte Chemical Titan Tbk PT (FPNI)?
The return on equity (ROE) of Lotte Chemical Titan Tbk PT is 16.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Lotte Chemical Titan Tbk PT (FPNI)?
On an EBIT basis the return on assets of Lotte Chemical Titan Tbk PT is −2.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Lotte Chemical Titan Tbk PT (FPNI)?
The operating margin of Lotte Chemical Titan Tbk PT is 8.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Lotte Chemical Titan Tbk PT (FPNI)?
Revenue at Lotte Chemical Titan Tbk PT is growing +41.9% versus a year earlier (3y avg −12.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Lotte Chemical Titan Tbk PT (FPNI)?
Earnings per share at Lotte Chemical Titan Tbk PT are growing +152% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Lotte Chemical Titan Tbk PT (FPNI) hold?
Lotte Chemical Titan Tbk PT holds more cash than debt, $39.5M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Lotte Chemical Titan Tbk PT in the live analysis
One click puts Lotte Chemical Titan Tbk PT on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Thin data
Oct 21, 2026